RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Slate Path Capital
S

Slate Path Capital portfolio

Slate Path Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is City Therapeutics's $99.5M Series B+ round in June 2026, alongside Viking Global Investors, Sofinnova Investments, Rock Springs Capital and 6 others. That company is in Health and bio. It has co-invested with Regeneron Ventures, Fidelity and ARCH Venture Partners, most often Regeneron Ventures (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $234.5M.
Latest deal: City Therapeutics · Jun 8, 2026.

What Slate Path Capital invests in

How Slate Path Capital invests

StageDealsCapital in rounds
Series B+ 1 50%$99.5M
Series A 1 50%$135M
YearDealsCapital in rounds
2024 1 50%$135M
2026 1 50%$99.5M

Share is of the 2 rounds on Recent Funding that name Slate Path Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Slate Path Capital portfolio companies

CompanyRound with Slate Path CapitalTotal raisedLatest raise
CCity Therapeutics
Health and bio
 Series B+ · $99.5M$234.5MJun 8, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Slate Path Capital, which is a subset of its real portfolio. API: /api/v1/investors/slate-path-capital (get a free API key). More: the most active VC firms and new venture capital funds.